Free Trial

Anpario (LON:ANP) Stock Passes Below 200-Day Moving Average - Should You Sell?

Anpario logo with Consumer Defensive background

Key Points

  • Anpario plc's stock price fell below its 200-day moving average during trading, reaching a low of GBX 371.25 ($4.93) while the latest trading price was GBX 381.50 ($5.06).
  • The company has a market capitalization of £65.09 million and a low debt-to-equity ratio of 0.10.
  • Anpario specializes in natural feed additives for animal health and nutrition, offering a range of products designed to support animal gut health and feed quality.
  • Want stock alerts on Anpario? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Anpario plc (LON:ANP - Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 420.40 ($5.59) and traded as low as GBX 371.25 ($4.94). Anpario shares last traded at GBX 381.50 ($5.07), with a volume of 30,619 shares trading hands.

Anpario Price Performance

The firm's fifty day moving average price is GBX 411.89 and its 200 day moving average price is GBX 419.28. The firm has a market capitalization of £66.04 million, a PE ratio of 21.37 and a beta of 0.58. The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.10.

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Read More

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines